http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013106565-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_115a7dee976a8cb6f8dcf38935046267
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_705dee5a28d30db256118c68a4e0ee63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f9a2d0869f8186f543dc6633be8ad63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a17e7d1f6792dfb52a8d0e2f827c2e23
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
filingDate 2013-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f38735a47c31082a6c19a253a8d890a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4898566e8bd223a26944f1bac735ce4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7190a949baf41fb0b4ed91eee855d34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_397b884397058f6d1f5e9ab04c76c67d
publicationDate 2013-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2013106565-A1
titleOfInvention Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide f2 alpha agonists
abstract The present invention is directed to compositions and methods for the treatment of post-chemotherapeutic hypotrichosis. More specifically, the present invention is directed to the use of compositions comprising bimatoprost for the treatment of post-chemotherapeutic hypotrichosis which may be applied before, during and after receiving chemotherapeutic treatment.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9216183-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11696915-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10987355-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11541053-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11541054-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11253518-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10993944-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11013600-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11166955-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022003929-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11369610-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9226931-B2
priorityDate 2012-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011002866-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007160562-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011119748-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419567175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397159
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57363
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411682
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415001522
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4201
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408176977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246850498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135743713
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393816

Total number of triples: 54.